[Skip to Content]
[Skip to Content Landing]
Article
August 23, 1952

PRIMAQUINE FOR VIVAX MALARIA

JAMA. 1952;149(17):1573. doi:10.1001/jama.1952.02930340057014

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

Elsewhere in The Journal (p. 1558) are four reports on malaria and drugs used in control of this disease. These reports provide much practical information for the medical profession and at the same time raise some points not previously appreciated by those not close to this field of investigation. Studies undertaken by the authors of the Council-sponsored reports and some of the results of studies on malaria therapy jointly undertaken by the Medical Research and Development Board of the United States Army, the United States Public Health Service, and the Subcommittee on Malaria of the Committee on Medicine of the National Research Council bring to the physicians of the United States a very practical problem.

When our forces entered Korea in the summer of 1950, chloroquine was administered routinely for the suppression of malaria. Chloroquine is an excellent suppressive drug, but it does not prevent infection with the malaria parasite.

First Page Preview View Large
First page PDF preview
First page PDF preview
×